Invesco S&P MidCap 400 GARP ETF Rating $136.76 +0.18 (+0.13%) As of 03:06 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort Interest Invesco S&P MidCap 400 GARP ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.GRPM Aggregate RatingModerate Buy 2.58Holdings in GRPM have an aggregate rating of Moderate Buy based on 363 analyst ratings issued in the past year covering 25 companies (55.4% of the portfolio).GRPM Aggregate Price Target$136.75-0.01% DownsideHigh Prediction$136.75Average Prediction$136.75Low Prediction$136.75Holdings in GRPM have an aggregate price target of $136.75 and a range of $136.75 to $136.75 covering 25 companies (55.4% of the portfolio).GRPM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold10 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco S&P MidCap 400 GARP ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 GRPM Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings3.24%ANFAbercrombie & Fitch$134.94+0.5%Moderate Buy$155.38 15.2%153.7014 of 5 stars2.91%HALOHalozyme Therapeutics$114.33-0.8%Moderate Buy$91.20 -20.2%132.6304 of 5 stars2.90%DUOLDuolingo$142.33-3.7%Hold$124.38 -12.6%243.1909 of 5 starsInsider Trade2.74%IDCCInterDigital$330.45+0.7%Buy$450.00 36.2%43.4564 of 5 stars2.64%HLHecla Mining$18.28+1.9%Hold$23.34 27.7%104.5773 of 5 stars2.61%APPFAppFolio$204.410.0%Moderate Buy$246.63 20.7%124.1332 of 5 starsNews CoverageAnalyst Downgrade2.39%RNRRenaissanceRe$326.36-1.2%Hold$338.13 3.6%183.2993 of 5 starsAnalyst Forecast2.36%KNSLKinsale Capital Group$333.02-2.2%Reduce$368.78 10.7%102.6088 of 5 starsPositive News2.35%MEDPMedpace$614.61-1.0%Hold$595.20 -3.2%122.42 of 5 starsInsider Trade2.30%PCTYPaylocity$143.84+0.1%Moderate Buy$160.53 11.6%173.6492 of 5 starsAnalyst Upgrade2.19%SNSharkNinja$178.33+0.8%Moderate Buy$188.59 5.8%133.6338 of 5 stars2.18%THCTenet Healthcare$256.11+2.6%Moderate Buy$277.25 8.3%213.3355 of 5 starsAnalyst Forecast2.17%FTITechnipFMC$70.71-0.3%Moderate Buy$70.00 -1.0%163.4388 of 5 starsInsider Trade2.14%DOCUDocusign$67.78-1.8%Hold$67.33 -0.7%182.531 of 5 stars2.13%QLYSQualys$175.01-4.3%Hold$173.87 -0.7%172.4958 of 5 starsInsider Trade2.02%LNTHLantheus$99.82+0.1%Hold$108.11 8.3%143.3206 of 5 stars1.98%EXELExelixis$58.36+0.7%Hold$50.29 -13.8%203.2131 of 5 stars1.85%SLMSLM$23.66+2.6%Hold$29.80 26.0%124.1907 of 5 starsPositive News1.84%MANHManhattan Associates$205.75-1.9%Moderate Buy$217.20 5.6%102.6371 of 5 stars1.80%DOCSDoximity$26.52+1.9%Hold$32.18 21.3%254.272 of 5 starsTrending News1.80%GMEDGlobus Medical$74.47+0.3%Moderate Buy$101.77 36.7%174.0892 of 5 stars1.76%TTEKTetra Tech$33.75+0.3%Moderate Buy$38.25 13.3%53.906 of 5 starsPositive News1.73%HLNEHamilton Lane$86.07+0.9%Moderate Buy$131.57 52.9%94.8206 of 5 stars1.67%NBIXNeurocrine Biosciences$138.20-0.5%Moderate Buy$201.09 45.5%244.8251 of 5 starsPositive News1.65%EXLSExlService$34.64-1.5%Moderate Buy$44.50 28.5%74.8006 of 5 starsPositive News This page (NYSEARCA:GRPM) was last updated on 9/25/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco S&P MidCap 400 GARP ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco S&P MidCap 400 GARP ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
